KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Research & Development (2020 - 2023)

Historic Research & Development for AbCellera Biologics (ABCL) over the last 4 years, with Q4 2023 value amounting to $48.6 million.

  • AbCellera Biologics' Research & Development rose 7214.37% to $48.6 million in Q4 2023 from the same period last year, while for Dec 2023 it was $175.7 million, marking a year-over-year increase of 6283.12%. This contributed to the annual value of $167.3 million for FY2024, which is 478.15% down from last year.
  • Latest data reveals that AbCellera Biologics reported Research & Development of $48.6 million as of Q4 2023, which was up 7214.37% from $37.9 million recorded in Q3 2023.
  • AbCellera Biologics' 5-year Research & Development high stood at $52.6 million for Q1 2023, and its period low was $4.1 million during Q1 2020.
  • Its 4-year average for Research & Development is $23.4 million, with a median of $21.9 million in 2021.
  • Per our database at Business Quant, AbCellera Biologics' Research & Development surged by 19995.14% in 2021 and then soared by 3667.98% in 2023.
  • AbCellera Biologics' Research & Development (Quarter) stood at $8.6 million in 2020, then skyrocketed by 99.27% to $17.2 million in 2021, then soared by 64.13% to $28.2 million in 2022, then soared by 72.14% to $48.6 million in 2023.
  • Its Research & Development stands at $48.6 million for Q4 2023, versus $37.9 million for Q3 2023 and $36.5 million for Q2 2023.